Terlipressin Acetate, High Assay Pharmaceutical Peptide

• Powder: Yes
• Customized: Customized
• Certification: GMP, HSE, ISO 9001, USP, BP
• Suitable for: Adult
• State: Solid
• Purity: >98%
• Model NO.: HJYY
• appearance: White Powder
• Water: Not More Than 5%
• Assay: 95%-105%
• Impurity: Not More Than 2%
• Transport Package: 5g/Al Bag
• Specification: 95.0%~103.0%
• Trademark: HD
• Origin: China
• HS Code: 2937190090
• Production Capacity: 100000g/Month

Product Description

 

Product Description

   Terlipressin is a vasopressin analogue with potent vasoactive properties. Terlipressin is a highly selective vasopressin V1 receptor agonist that reduces the splanchnic blood flow and portal pressure and controls acute variceal bleeding. Terlipressin exerts anti-inflammatory and anti-oxidative effects. Terlipressin has the potential for hepatorenal syndrome and norepinephrine-resistant septic shock research.

Detailed Photos

Product Parameters

Product Introduction

 

Generic name	Terlipressin Acetate
Formula	C52H74N16O15S2
CAS No.	14636-12-5
Molecular Weight	1227.37
EINECS	238-680-8
Grade	Pharma Grade
Shelf Life	2 Years
Purity	99%
Appearance	White to off-white

  Chemical Properties

Melting Point	>170°C (dec.)
Boling Point	1824.0±65.0 °C(Predicted)
Density	1.46±0.1 g/cm3(Predicted)
Refractive Index	1.664
Storage Condition	Keep in dark place,Inert atmosphere,Store in freezer,   under -20°C
pka	9.90±0.15(Predicted)
Color	White

Application & Efficacy

    Terlipressin can improve liver and kidney function, reverse HRS and prolong the survival time of HRS patients, thus prolonging the waiting time for liver transplantation. At the same time, terlipressin is an important therapeutic drug for patients with esophageal variceal bleeding in emergency situations, and is the only drug that has been proven to prolong the survival time of patients with esophageal variceal bleeding. In addition, terlipressin has a certain effect in the treatment of refractory shock, cirrhosis ascites, hypotension during surgery and cardiac arrest in children, and has a good clinical application prospect.
 

Company Profile